Blueberries Medical Corp.
BBM
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -113.88% | 46.25% | -25.46% | 31.19% | -15.30% |
| Total Depreciation and Amortization | -0.51% | 8.94% | -10.50% | -22.18% | -65.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 670.33% | -127.08% | 152.63% | -80.03% | 7,300.00% |
| Change in Net Operating Assets | 47.27% | -148.46% | 443.94% | 61.40% | -192.43% |
| Cash from Operations | -9.61% | -36.93% | 30.72% | -3.00% | -19.77% |
| Capital Expenditure | -- | -- | -- | -- | 33.33% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -1,259.21% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | 608.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 91.67% | -140.00% | 99.96% | -10,551.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 88.89% | -125.00% | -100.09% | 4,469.39% |
| Foreign Exchange rate Adjustments | 1,345.83% | 108.76% | -258.38% | 108.10% | -316.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.31% | -14.88% | 8.87% | -185.60% | 774.59% |